180 related articles for article (PubMed ID: 10393290)
21. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[TBL] [Abstract][Full Text] [Related]
22. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
Williams RO; Repka M; Liu J
Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
[TBL] [Abstract][Full Text] [Related]
23. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
24. What is new in asthma: new dry powder inhalers.
Hannemann LA
J Pediatr Health Care; 1999; 13(4):159-65. PubMed ID: 10690079
[TBL] [Abstract][Full Text] [Related]
25. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
26. Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
Hartung TK; Allbutt H; Dewar M; Innes JA; Crompton GK
Respiration; 2002; 69(4):314-9. PubMed ID: 12169743
[TBL] [Abstract][Full Text] [Related]
27. Metered-dose inhalers, dry powder inhalers, and transitions.
Fink JB
Respir Care; 2000 Jun; 45(6):623-35. PubMed ID: 10894455
[TBL] [Abstract][Full Text] [Related]
28. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
Harrison LI
J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
[TBL] [Abstract][Full Text] [Related]
29. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
30. Transition to CFC-free metered dose inhalers--into the new millennium.
McDonald KJ; Martin GP
Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
[TBL] [Abstract][Full Text] [Related]
31. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
32. The president speaks: prevention is best: lessons from protecting the ozone layer.
Woodcock A
Thorax; 2012 Dec; 67(12):1028-31. PubMed ID: 23019254
[TBL] [Abstract][Full Text] [Related]
33. Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction.
Matthys H
Respiration; 1996; 63(6):321-4. PubMed ID: 8933648
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
35. Aerosol devices and asthma therapy.
Berger W
Curr Drug Deliv; 2009 Jan; 6(1):38-49. PubMed ID: 19418954
[TBL] [Abstract][Full Text] [Related]
36. Issues surrounding MDI formulation development with non-CFC propellants.
Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
[TBL] [Abstract][Full Text] [Related]
37. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Boccuzzi SJ; Wogen J; Roehm JB
Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
[TBL] [Abstract][Full Text] [Related]
38. The challenge of reformulation.
Smith IJ
J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
[TBL] [Abstract][Full Text] [Related]
39. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C; Guerriero M; Tognella S; Dal Negro RW
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[TBL] [Abstract][Full Text] [Related]
40. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
Cheng YS; Fu CS; Yazzie D; Zhou Y
J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
